CORDIS · 101080465 · HORIZON

OBELISK Fighting childhood obesity to stay healthy all over the life

Coordinator: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR)

Obesity rates in late teens have increased in Europe from 6% in 1980 to 32%, with long-lasting effects on the prevalence of severe obesity, diabetes and cardiovascular disease, premature death and disability. Efficiently fighting adult obesity is difficult but prevention and treatment of obesity have proven to work better at young ages. OBELISK goal is to cut the roots of the pandemic of obesity in Europe targeting children first. OBELISK is focused on elucidating, Predicting, Preventing obesity and bringing Precision medicine for children with obesity. OBELISK medicine is also Participative …

EU contribution
€10.1M
Total cost
€10.1M
Period
2023-05-01 → 2028-04-30
Framework
Horizon Europe (2021–2027)
Funding scheme
HORIZON-RIA
Call
HORIZON-HLTH-2022-STAYHLTH-01-two-stage
Status
SIGNED

About Horizon Europe (2021–2027)

Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.

EU contribution: €10.1M awarded to the consortium. The project runs over approximately 5 years from 2023-05-01 to 2028-04-30.

Full record on CORDIS — partners, deliverables, publications, news.

Open on cordis.europa.eu → Grant DOI ↗

Frequently asked questions

Who funds this research project?
This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-RIA funding scheme.
What is the EU contribution?
The European Commission contributes €10.1M toward a total project budget of €10.1M.
Which EU programme funds it?
The project is funded under Horizon Europe (2021–2027), call HORIZON-HLTH-2022-STAYHLTH-01-two-stage.
Who coordinates the project?
The project is coordinated by INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR).
What is the project timeline?
The project runs from 2023-05-01 to 2028-04-30 — approximately 5 years.
Where can I find the full project record?
The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101080465.